Paula Green, SVP of Human Resources at Twist Bioscience Corp, filed a statement of changes in beneficial ownership on November 16, 2026, reporting the acquisition of 20,429 shares of common stock through Performance Stock Units on November 12, 2026.
Key Highlights
- Reporting person: Paula Green, SVP of Human Resources at Twist Bioscience Corp (NASDAQ:TWST)
- Transaction date: November 12, 2026, with the filing submitted on November 16, 2026
- Shares acquired: 20,429 shares of common stock via Performance Stock Units, at a price of $0
- Post-transaction ownership: Green directly holds 126,054 shares of common stock following the reported transaction
- PSU condition: Target criteria for the Performance Stock Units were determined to have been met on November 12, 2026
- Remaining vesting: 60% of the PSUs remain subject to time-based vesting, with vesting scheduled for September 30, 2027, subject to continued service
PSU Award Details and Vesting Terms for Twist Bioscience's HR Chief
According to the filing, the transaction recorded under transaction code "A" reflects an acquisition of 20,429 shares of Twist Bioscience Corp common stock by Paula Green in her capacity as SVP of Human Resources. The shares were received through Performance Stock Units at a reported price of $0, meaning no cash consideration was exchanged. Twist Bioscience, headquartered at 681 Gateway Blvd., South San Francisco, California, is a synthetic biology company engaged in DNA synthesis and related bioscience products.
The filing's footnote explains that the 20,429 shares "represent Performance Stock Units for which target criteria was determined to have been met on November 12, 2026." However, the transaction does not mark a full and unconditional vesting. As disclosed, "60% of the PSUs remain subject to time-based vesting and will vest on September 30, 2027, subject to continued service." This means a portion of the awarded units continues to carry a future vesting obligation tied to Green's employment with the company. Following the reported transaction, Green's total direct beneficial ownership stands at 126,054 shares of common stock. The filing was signed by Kendra Fox as attorney-in-fact for Paula Green and submitted on November 16, 2026, with no derivative securities reported in Table II.
What Was Disclosed
Twist Bioscience Corp's SVP of Human Resources, Paula Green, disclosed the acquisition of 20,429 shares of common stock through Performance Stock Units, with performance criteria met on November 12, 2026. Post-transaction, Green directly holds 126,054 shares, with 60% of the PSUs still subject to time-based vesting through September 30, 2027.




Please wait processing your request...